Hunan Jiudian Pharmaceutical Co Ltd
SZSE:300705
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hunan Jiudian Pharmaceutical Co Ltd
SZSE:300705
|
CN |
|
D
|
Destek Finans Faktoring AS
IST:DSTKF.E
|
TR |
|
T
|
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
SZSE:000766
|
CN |
|
Fujian Wanchen Biotechnology Co Ltd
SZSE:300972
|
CN |
|
L
|
La Doria SpA
F:2DO
|
IT |
|
Sanken Electric Co Ltd
OTC:SANJF
|
JP |
|
Zhengzhou Qianweiyangchu Food Co Ltd
SZSE:001215
|
CN |
|
K
|
Kamux Oyj
OMXH:KAMUX
|
FI |
|
C
|
China CAMC Engineering Co Ltd
SZSE:002051
|
CN |
|
Shenzhen Rapoo Technology Co Ltd
SZSE:002577
|
CN |
|
Centum Electronics Ltd
NSE:CENTUM
|
IN |
|
Bioera SpA
MIL:BIE
|
IT |
|
E
|
Empower India Ltd
BSE:504351
|
IN |
|
Aisin Corp
TSE:7259
|
JP |
Bankruptcy Probability
Hunan Jiudian Pharmaceutical Co Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Hunan Jiudian Pharmaceutical Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
|
Hunan Jiudian Pharmaceutical Co Ltd
SZSE:300705
|
6.6B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
860.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Hunan Jiudian Pharmaceutical Co Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Hunan Jiudian Pharmaceutical Co Ltd has total debt of 454.8m CNY. This includes both short-term (0 CNY) and long-term (454.8m CNY) debt.
You can find a full breakdown on its Balance Sheet.
